The study by Li et al. 19 investigated the clinicopathological parameters of H19 in ESCC patients, revealing that increased H19 expression was associated with larger tumor size, poor clinical stage, and shorter OS. This evidence concerns the gene H19 and esophageal squamous cell carcinoma.